Show Search Form

Search Results

human indexable	true false
published	true false
registered interest	true false
answer date	exactly: or between: and
date	exactly: or between: and
date tabled	exactly: or between: and
ddp created	exactly: or between: and
answering body
question status
answering dept id
answering dept short name
answering dept sort name
ddp modified
hansard heading
house id
identifier
legislature	pref label
parliament number
question first answered
question text
session
session number
tabling member constituency
tabling member printed
title
type
uin
version
written parliamentary question type
answer
creator	label
publisher	pref label
tabling member	label

Search

1668183

human indexable
published
registered interest
answer date	13/11/2023
date	07/11/2023
date tabled	07/11/2023
ddp created	07/11/2023 22:37:25
answering body	Department of Health and Social Care
question status	Tabled
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
ddp modified	07/11/2023 23:15:42 13/11/2023 11:11:17
hansard heading	Accident and Emergency Departments: Sotrovimab
house id	1
identifier	500
legislature	25259 pref label House of Commons
parliament number	58
question first answered	13/11/2023 10:39:40
question text	To ask the Secretary of State for Health and Social Care, how many and what proportion of hospitals with accident and emergency units have supplies of Sotrovimab.
session	2023/24
session number	4
tabling member constituency	St Albans
tabling member printed	Daisy Cooper
title	House of Commons Tabled Parliamentary Question 2023/24 500
type	WrittenParliamentaryQuestion
uin	500
version	1
written parliamentary question type	NamedDay
answer	answer
creator	4769 label Biography information for Daisy Cooper
publisher	25259 pref label House of Commons
tabling member	4769 label Biography information for Daisy Cooper

1668185

human indexable
published
registered interest
answer date	13/11/2023
date	07/11/2023
date tabled	07/11/2023
ddp created	07/11/2023 22:37:36
answering body	Department of Health and Social Care
question status	Tabled
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
ddp modified	07/11/2023 23:15:53 13/11/2023 11:11:14
hansard heading	Sotrovimab
house id	1
identifier	501
legislature	25259 pref label House of Commons
parliament number	58
question first answered	13/11/2023 10:39:41
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the adequacy of the supply of anti-viral drug Sotrovimab for immunocompromised patients.
session	2023/24
session number	4
tabling member constituency	St Albans
tabling member printed	Daisy Cooper
title	House of Commons Tabled Parliamentary Question 2023/24 501
type	WrittenParliamentaryQuestion
uin	501
version	1
written parliamentary question type	NamedDay
answer	answer
creator	4769 label Biography information for Daisy Cooper
publisher	25259 pref label House of Commons
tabling member	4769 label Biography information for Daisy Cooper

1668298

human indexable
published
registered interest
answer date	13/11/2023
date	08/11/2023
date tabled	08/11/2023
ddp created	08/11/2023 19:52:33
answering body	Department of Health and Social Care
question status	Tabled
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
ddp modified	08/11/2023 19:55:44 13/11/2023 11:15:36
hansard heading	Cystic Fibrosis: Medical Treatments
house id	1
identifier	710
legislature	25259 pref label House of Commons
parliament number	58
question first answered	13/11/2023 10:43:17
question text	To ask the Secretary of State for Health and Social Care, if he will take steps to ensure the continued NHS funding of modulator therapies that are used to treat (a) children, (b) new patients and (c) other patients with cystic fibrosis.
session	2023/24
session number	4
tabling member constituency	East Londonderry
tabling member printed	Mr Gregory Campbell
title	House of Commons Tabled Parliamentary Question 2023/24 710
type	WrittenParliamentaryQuestion
uin	710
version	1
written parliamentary question type	NamedDay
answer	answer
creator	1409 label Biography information for Mr Gregory Campbell
publisher	25259 pref label House of Commons
tabling member	1409 label Biography information for Mr Gregory Campbell

1668572

human indexable
published
registered interest
answer date	13/11/2023
date	08/11/2023
date tabled	08/11/2023
ddp created	08/11/2023 20:22:20
answering body	Department of Health and Social Care
question status	Tabled
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
ddp modified	08/11/2023 20:31:39 13/11/2023 11:17:15
hansard heading	Prescription Drugs
house id	1
identifier	882
legislature	25259 pref label House of Commons
parliament number	58
question first answered	13/11/2023 10:45:48
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to help ensure adequate levels of supply of medication prescribed for (a) epilepsy, (b) hormone replacement therapy and (c) ADHD.
session	2023/24
session number	4
tabling member constituency	Bedford
tabling member printed	Mohammad Yasin
title	House of Commons Tabled Parliamentary Question 2023/24 882
type	WrittenParliamentaryQuestion
uin	882
version	1
written parliamentary question type	NamedDay
answer	answer
creator	4598 label Biography information for Mohammad Yasin
publisher	25259 pref label House of Commons
tabling member	4598 label Biography information for Mohammad Yasin

1667521

human indexable
published
registered interest
answer date	09/11/2023
date	07/11/2023
date tabled	07/11/2023
ddp created	07/11/2023 21:38:13
answering body	Department of Health and Social Care
question status	Tabled
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
ddp modified	07/11/2023 21:45:37 09/11/2023 18:22:19
hansard heading	Antibiotics
house id	1
identifier	220
legislature	25259 pref label House of Commons
parliament number	58
question first answered	09/11/2023 17:51:11
question text	To ask the Secretary of State for Health and Social Care, whether he plans to take steps to make (a) Cefiderocol and (b) Ceftazidimethose available on the NHS.
session	2023/24
session number	4
tabling member constituency	Strangford
tabling member printed	Jim Shannon
title	House of Commons Tabled Parliamentary Question 2023/24 220
type	WrittenParliamentaryQuestion
uin	220
version	1
written parliamentary question type	Ordinary
answer	answer
creator	4131 label Biography information for Jim Shannon
publisher	25259 pref label House of Commons
tabling member	4131 label Biography information for Jim Shannon

1667523

human indexable
published
registered interest
answer date	09/11/2023
date	07/11/2023
date tabled	07/11/2023
ddp created	07/11/2023 21:38:23
answering body	Department of Health and Social Care
question status	Tabled
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
ddp modified	07/11/2023 21:45:47 09/11/2023 10:57:13
hansard heading	Osteoporosis: Romosozumab
house id	1
identifier	222
legislature	25259 pref label House of Commons
parliament number	58
question first answered	09/11/2023 10:25:40
question text	To ask the Secretary of State for Health and Social Care, whether his Department has a planned timescale for when romosozumab will be available in the NHS for the treatment of Osteoporosis.
session	2023/24
session number	4
tabling member constituency	Strangford
tabling member printed	Jim Shannon
title	House of Commons Tabled Parliamentary Question 2023/24 222
type	WrittenParliamentaryQuestion
uin	222
version	1
written parliamentary question type	Ordinary
answer	answer
creator	4131 label Biography information for Jim Shannon
publisher	25259 pref label House of Commons
tabling member	4131 label Biography information for Jim Shannon

1667530

human indexable
published
registered interest
answer date	09/11/2023
date	07/11/2023
date tabled	07/11/2023
ddp created	07/11/2023 21:39:11
answering body	Department of Health and Social Care
question status	Tabled
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
ddp modified	07/11/2023 21:46:25 09/11/2023 18:24:14
hansard heading	Health: Working Hours
house id	1
identifier	523
legislature	25259 pref label House of Commons
parliament number	58
question first answered	09/11/2023 17:52:28
question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential impact of night work on (a) the level of risk of diagnosis with diabetes, (b) the level of risk of diagnosis with cardiovascular disease and (c) other health outcomes.
session	2023/24
session number	4
tabling member constituency	Coventry North West
tabling member printed	Taiwo Owatemi
title	House of Commons Tabled Parliamentary Question 2023/24 523
type	WrittenParliamentaryQuestion
uin	523
version	1
written parliamentary question type	Ordinary
answer	answer
creator	4779 label Biography information for Taiwo Owatemi
publisher	25259 pref label House of Commons
tabling member	4779 label Biography information for Taiwo Owatemi

1667704

human indexable
published
registered interest
answer date	09/11/2023
date	07/11/2023
date tabled	07/11/2023
ddp created	07/11/2023 21:56:26
answering body	Department of Health and Social Care
question status	Tabled
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
ddp modified	07/11/2023 22:25:55 09/11/2023 18:29:20
hansard heading	Ferric Maltol: Chipping Barnet
house id	1
identifier	104
legislature	25259 pref label House of Commons
parliament number	58
question first answered	09/11/2023 17:57:40
question text	To ask the Secretary of State for Health and Social Care, if he will take steps to ensure that Ferric Maltol is available on prescription to people in Chipping Barnet constituency.
session	2023/24
session number	4
tabling member constituency	Chipping Barnet
tabling member printed	Theresa Villiers
title	House of Commons Tabled Parliamentary Question 2023/24 104
type	WrittenParliamentaryQuestion
uin	104
version	1
written parliamentary question type	Ordinary
answer	answer
creator	1500 label Biography information for Theresa Villiers
publisher	25259 pref label House of Commons
tabling member	1500 label Biography information for Theresa Villiers

1667958

human indexable
published
registered interest
answer date	09/11/2023
date	07/11/2023
date tabled	07/11/2023
ddp created	07/11/2023 22:19:25
answering body	Department of Health and Social Care
question status	Tabled
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
ddp modified	07/11/2023 23:04:09 09/11/2023 18:29:19
hansard heading	Cystic Fibrosis: Drugs
house id	1
identifier	346
legislature	25259 pref label House of Commons
parliament number	58
question first answered	09/11/2023 17:59:10
question text	To ask the Secretary of State for Health and Social Care, whether it is his Department's policy that people with cystic fibrosis will have access to (a) Orkambi, (b) Symkevi and (c) Kaftrio through the NHS.
session	2023/24
session number	4
tabling member constituency	Hornsey and Wood Green
tabling member printed	Catherine West
title	House of Commons Tabled Parliamentary Question 2023/24 346
type	WrittenParliamentaryQuestion
uin	346
version	1
written parliamentary question type	Ordinary
answer	answer
creator	4523 label Biography information for Catherine West
publisher	25259 pref label House of Commons
tabling member	4523 label Biography information for Catherine West

1668018

human indexable
published
registered interest
answer date	09/11/2023
date	07/11/2023
date tabled	07/11/2023
ddp created	07/11/2023 22:26:11
answering body	Department of Health and Social Care
question status	Tabled
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
ddp modified	07/11/2023 23:08:30 09/11/2023 11:31:14
hansard heading	Abiraterone
house id	1
identifier	377
legislature	25259 pref label House of Commons
parliament number	58
question first answered	09/11/2023 11:00:41
question text	To ask the Secretary of State for Health and Social Care, if he will review the decision to reject the use of the drug Abiraterone to tackle prostate cancer.
session	2023/24
session number	4
tabling member constituency	Richmond Park
tabling member printed	Sarah Olney
title	House of Commons Tabled Parliamentary Question 2023/24 377
type	WrittenParliamentaryQuestion
uin	377
version	1
written parliamentary question type	Ordinary
answer	answer
creator	4591 label Biography information for Sarah Olney
publisher	25259 pref label House of Commons
tabling member	4591 label Biography information for Sarah Olney